Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
330.30
+1.21 (0.37%)
May 8, 2026, 11:04 AM EDT - Market open
Amgen Stock Forecast
Stock Price Forecast
The 18 analysts that cover Amgen stock have a consensus rating of "Hold" and an average price target of $354.83, which forecasts a 7.43% increase in the stock price over the next year. The lowest target is $272 and the highest is $432.
Price Target: $354.83 (+7.43%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Amgen stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 12 | 12 | 13 | 14 | 13 | 12 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 17 | 19 | 20 | 19 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Hold Maintains $351 → $340 | Hold | Maintains | $351 → $340 | +2.94% | May 4, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $325 → $327 | Hold | Maintains | $325 → $327 | -1.00% | May 1, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Initiates $366 | Hold | Initiates | $366 | +10.81% | Apr 21, 2026 |
| UBS | UBS | Strong Buy Maintains $390 → $400 | Strong Buy | Maintains | $390 → $400 | +21.10% | Apr 13, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $309 → $326 | Hold | Maintains | $309 → $326 | -1.30% | Apr 10, 2026 |
Financial Forecast
Revenue This Year
38.53B
from 36.75B
Increased by 4.83%
Revenue Next Year
39.48B
from 38.53B
Increased by 2.48%
EPS This Year
22.82
from 14.23
Increased by 60.35%
EPS Next Year
23.94
from 22.82
Increased by 4.94%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 40.4B | 44.2B | ||||||
| Avg | 38.5B | 39.5B | ||||||
| Low | 36.4B | 36.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 9.9% | 14.8% | ||||||
| Avg | 4.8% | 2.5% | ||||||
| Low | -1.1% | -6.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 24.34 | 26.12 | ||||||
| Avg | 22.82 | 23.94 | ||||||
| Low | 21.15 | 21.03 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 71.0% | 14.5% | ||||||
| Avg | 60.4% | 4.9% | ||||||
| Low | 48.6% | -7.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.